Skip to main content
Erschienen in: Diabetologia 4/2008

01.04.2008 | Article

Type of preadmission glucose-lowering treatment and prognosis among patients hospitalised with myocardial infarction: a nationwide follow-up study

verfasst von: H. T. Horsdal, S. P. Johnsen, F. Søndergaard, J. Rungby

Erschienen in: Diabetologia | Ausgabe 4/2008

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

We examined whether the type of preadmission glucose-lowering treatments explained differences in mortality rate and risk of readmission with myocardial infarction (MI) and heart failure following first-time hospitalisation for MI in patients with type 2 diabetes mellitus.

Methods

We conducted a nationwide population-based follow-up study among all Danish patients hospitalised with first-time MI from 1996 to 2004. Data on use of glucose-lowering drugs and other medications, comorbidities, socioeconomic status, laboratory findings, readmission with MI and heart failure, and death were obtained from medical databases. We computed mortality rates and rates of MI and heart failure readmission, according to type of glucose-lowering treatment and used Cox’s proportional hazards regression analysis to compute hazard ratios (HRs) as estimates of relative risks.

Results

We identified 8,494 MI patients with type 2 diabetes mellitus. The overall cumulative 30 day and 1 year mortality rates were 22.2 and 36.6%, respectively. Patients not receiving any glucose-lowering drugs (adjusted 30 day HR: 0.79, 95% CI: 0.57–1.10) and users of any combination (adjusted 30 day HR: 1.43, 95% CI: 0.98–2.09) had the lowest and highest mortality rates, respectively, when compared with users of sulfonylureas. We found that glycaemic control had no impact on the risk estimates in a subanalysis including biochemical laboratory data. We found no differences in the risk of new MI and heart failure between the different glucose-lowering agents.

Conclusions/interpretation

Type of preadmission glucose-lowering treatment in monotherapy is not associated with substantial differences in prognosis following hospitalisation with MI. However, patients treated with any combination had increased mortality rates.
Literatur
1.
Zurück zum Zitat Turner RC, Cull CA, Frighi V, Holman RR (1999) Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 281:2005–2012PubMedCrossRef Turner RC, Cull CA, Frighi V, Holman RR (1999) Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 281:2005–2012PubMedCrossRef
2.
Zurück zum Zitat Malmberg K, Yusuf S, Gerstein HC et al (2000) Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation 102:1014–1019PubMed Malmberg K, Yusuf S, Gerstein HC et al (2000) Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation 102:1014–1019PubMed
3.
Zurück zum Zitat Meinert CL, Knatterud GL, Prout TE, Klimt CR (1970) A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results. Diabetes 19(Suppl):789–830PubMed Meinert CL, Knatterud GL, Prout TE, Klimt CR (1970) A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results. Diabetes 19(Suppl):789–830PubMed
4.
Zurück zum Zitat Davis TM, Parsons RW, Broadhurst RJ, Hobbs MS, Jamrozik K (1998) Arrhythmias and mortality after myocardial infarction in diabetic patients. Relationship to diabetes treatment. Diabetes Care 21:637–640PubMedCrossRef Davis TM, Parsons RW, Broadhurst RJ, Hobbs MS, Jamrozik K (1998) Arrhythmias and mortality after myocardial infarction in diabetic patients. Relationship to diabetes treatment. Diabetes Care 21:637–640PubMedCrossRef
5.
Zurück zum Zitat Inzucchi SE, Masoudi FA, Wang Y et al (2005) Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial infarction: insights from the National Heart Care Project. Diabetes Care 28:1680–1689PubMedCrossRef Inzucchi SE, Masoudi FA, Wang Y et al (2005) Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial infarction: insights from the National Heart Care Project. Diabetes Care 28:1680–1689PubMedCrossRef
6.
Zurück zum Zitat Meier JJ, Deifuss S, Klamann A, Schmiegel W, Nauck MA (2003) Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA). Exp Clin Endocrinol Diabetes 111:344–350PubMedCrossRef Meier JJ, Deifuss S, Klamann A, Schmiegel W, Nauck MA (2003) Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA). Exp Clin Endocrinol Diabetes 111:344–350PubMedCrossRef
7.
Zurück zum Zitat Johnsen SP, Monster TB, Olsen ML et al (2006) Risk and short-term prognosis of myocardial infarction among users of antidiabetic drugs. Am J Ther 13:134–140PubMedCrossRef Johnsen SP, Monster TB, Olsen ML et al (2006) Risk and short-term prognosis of myocardial infarction among users of antidiabetic drugs. Am J Ther 13:134–140PubMedCrossRef
8.
Zurück zum Zitat Garratt KN, Brady PA, Hassinger NL, Grill DE, Terzic A, Holmes DR Jr (1999) Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. J Am Coll Cardiol 33:119–124PubMedCrossRef Garratt KN, Brady PA, Hassinger NL, Grill DE, Terzic A, Holmes DR Jr (1999) Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. J Am Coll Cardiol 33:119–124PubMedCrossRef
9.
Zurück zum Zitat Gustafsson I, Hildebrandt P, Seibaek M et al (2000) Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen. The TRACE Study Group. Eur Heart J 21:1937–1943PubMedCrossRef Gustafsson I, Hildebrandt P, Seibaek M et al (2000) Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen. The TRACE Study Group. Eur Heart J 21:1937–1943PubMedCrossRef
10.
Zurück zum Zitat Fisman EZ, Tenenbaum A, Benderly M, Goldbourt U, Behar S, Motro M (1999) Antihyperglycemic treatment in diabetics with coronary disease: increased metformin-associated mortality over a 5-year follow-up. Cardiology 91:195–202PubMedCrossRef Fisman EZ, Tenenbaum A, Benderly M, Goldbourt U, Behar S, Motro M (1999) Antihyperglycemic treatment in diabetics with coronary disease: increased metformin-associated mortality over a 5-year follow-up. Cardiology 91:195–202PubMedCrossRef
11.
Zurück zum Zitat Halkin A, Roth A, Jonas M, Behar S (2001) Sulfonylureas are not associated with increased mortality in diabetics treated with thrombolysis for acute myocardial infarction. J Thromb Thrombolysis 12:177–184PubMedCrossRef Halkin A, Roth A, Jonas M, Behar S (2001) Sulfonylureas are not associated with increased mortality in diabetics treated with thrombolysis for acute myocardial infarction. J Thromb Thrombolysis 12:177–184PubMedCrossRef
12.
Zurück zum Zitat McGuire DK, Newby LK, Bhapkar MV et al (2004) Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes. Am Heart J 147:246–252PubMedCrossRef McGuire DK, Newby LK, Bhapkar MV et al (2004) Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes. Am Heart J 147:246–252PubMedCrossRef
13.
Zurück zum Zitat Murcia AM, Hennekens CH, Lamas GA et al (2004) Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction. Arch Intern Med 164:2273–2279PubMedCrossRef Murcia AM, Hennekens CH, Lamas GA et al (2004) Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction. Arch Intern Med 164:2273–2279PubMedCrossRef
14.
Zurück zum Zitat Fisman EZ, Tenenbaum A, Boyko V et al (2001) Oral antidiabetic treatment in patients with coronary disease: time-related increased mortality on combined glyburide/metformin therapy over a 7.7-year follow-up. Clin Cardiol 24:151–158PubMedCrossRef Fisman EZ, Tenenbaum A, Boyko V et al (2001) Oral antidiabetic treatment in patients with coronary disease: time-related increased mortality on combined glyburide/metformin therapy over a 7.7-year follow-up. Clin Cardiol 24:151–158PubMedCrossRef
15.
16.
Zurück zum Zitat Pedersen CB, Gotzsche H, Moller JO, Mortensen PB (2006) The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 53:441–449PubMed Pedersen CB, Gotzsche H, Moller JO, Mortensen PB (2006) The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 53:441–449PubMed
17.
Zurück zum Zitat Andersen TF, Madsen M, Jørgensen J, Mellemkjoer L, Olsen JH (1999) The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 46:263–268PubMed Andersen TF, Madsen M, Jørgensen J, Mellemkjoer L, Olsen JH (1999) The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 46:263–268PubMed
18.
Zurück zum Zitat Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A (1994) Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90:583–612PubMed Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A (1994) Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90:583–612PubMed
19.
Zurück zum Zitat Statistics Denmark (1991) IDA—an integrated database for labour market research. Statistics Denmark, Copenhagen Statistics Denmark (1991) IDA—an integrated database for labour market research. Statistics Denmark, Copenhagen
20.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383PubMedCrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383PubMedCrossRef
21.
Zurück zum Zitat Steen H, Giannitsis E, Futterer S, Merten C, Juenger C, Katus HA (2006) Cardiac troponin T at 96 hours after acute myocardial infarction correlates with infarct size and cardiac function. J Am Coll Cardiol 48:2192–2194PubMedCrossRef Steen H, Giannitsis E, Futterer S, Merten C, Juenger C, Katus HA (2006) Cardiac troponin T at 96 hours after acute myocardial infarction correlates with infarct size and cardiac function. J Am Coll Cardiol 48:2192–2194PubMedCrossRef
22.
Zurück zum Zitat Madsen M, Balling H, Eriksen LS (1990) The validity of the diagnosis of acute myocardial infarction in 2 registries: the Heart Registry compared to the National Patient Registry. Ugeskr Laeger 152:308–314 (article in Danish)PubMed Madsen M, Balling H, Eriksen LS (1990) The validity of the diagnosis of acute myocardial infarction in 2 registries: the Heart Registry compared to the National Patient Registry. Ugeskr Laeger 152:308–314 (article in Danish)PubMed
23.
Zurück zum Zitat Nielsen GL, Sørensen HT, Pedersen AB, Sabroe S (1996) Analyses of data quality in registries concerning diabetes mellitus—a comparison between a population based hospital discharge and an insulin prescription registry. J Med Syst 20:1–10PubMedCrossRef Nielsen GL, Sørensen HT, Pedersen AB, Sabroe S (1996) Analyses of data quality in registries concerning diabetes mellitus—a comparison between a population based hospital discharge and an insulin prescription registry. J Med Syst 20:1–10PubMedCrossRef
24.
Zurück zum Zitat Lachin JM, Christophi CA, Edelstein SL et al (2007) Factors associated with diabetes onset during metformin versus placebo therapy in the diabetes prevention program. Diabetes 56:1153–1159PubMedCrossRef Lachin JM, Christophi CA, Edelstein SL et al (2007) Factors associated with diabetes onset during metformin versus placebo therapy in the diabetes prevention program. Diabetes 56:1153–1159PubMedCrossRef
25.
Zurück zum Zitat Kronborg J, Johnsen SH, Njolstad I, Toft I, Eriksen BO, Jenssen T (2007) Proinsulin:insulin and insulin:glucose ratios as predictors of carotid plaque growth: a population-based 7 year follow-up of the Tromso Study. Diabetologia 50:1607–1614PubMedCrossRef Kronborg J, Johnsen SH, Njolstad I, Toft I, Eriksen BO, Jenssen T (2007) Proinsulin:insulin and insulin:glucose ratios as predictors of carotid plaque growth: a population-based 7 year follow-up of the Tromso Study. Diabetologia 50:1607–1614PubMedCrossRef
26.
Zurück zum Zitat UK Prospective Diabetes Study (UKPDS) Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854–865CrossRef UK Prospective Diabetes Study (UKPDS) Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854–865CrossRef
27.
Zurück zum Zitat Kao J, Tobis J, McClelland RL et al (2004) Relation of metformin treatment to clinical events in diabetic patients undergoing percutaneous intervention. Am J Cardiol 93:1347–1350PubMedCrossRef Kao J, Tobis J, McClelland RL et al (2004) Relation of metformin treatment to clinical events in diabetic patients undergoing percutaneous intervention. Am J Cardiol 93:1347–1350PubMedCrossRef
28.
Zurück zum Zitat McAfee AT, Koro C, Landon J, Ziyadeh N, Walker AM (2007) Coronary heart disease outcomes in patients receiving antidiabetic agents. Pharmacoepidemiol Drug Saf 16:711–725PubMedCrossRef McAfee AT, Koro C, Landon J, Ziyadeh N, Walker AM (2007) Coronary heart disease outcomes in patients receiving antidiabetic agents. Pharmacoepidemiol Drug Saf 16:711–725PubMedCrossRef
29.
Zurück zum Zitat Sauer WH, Cappola AR, Berlin JA, Kimmel SE (2006) Insulin sensitizing pharmacotherapy for prevention of myocardial infarction in patients with diabetes mellitus. Am J Cardiol 97:651–654PubMedCrossRef Sauer WH, Cappola AR, Berlin JA, Kimmel SE (2006) Insulin sensitizing pharmacotherapy for prevention of myocardial infarction in patients with diabetes mellitus. Am J Cardiol 97:651–654PubMedCrossRef
Metadaten
Titel
Type of preadmission glucose-lowering treatment and prognosis among patients hospitalised with myocardial infarction: a nationwide follow-up study
verfasst von
H. T. Horsdal
S. P. Johnsen
F. Søndergaard
J. Rungby
Publikationsdatum
01.04.2008
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 4/2008
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-008-0947-6

Weitere Artikel der Ausgabe 4/2008

Diabetologia 4/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.